Document details

According to Scheinberg, et al. (2015) citing Bianchi ML. (2013) Cerebral Palsy (CP) is one of the most prevalent diseases within those that affect bone mass, and is often related to other pathologies such as osteoporosis. According to António, D., H., et al, (2020) citing NIH, (2002); WHO, (2003) osteoporosis is a pathology that involves others and is defined by the deterioration of bone tissue. In this way, with the alterations caused in the bone tissue and with the reduced BMD values, the bones lose resistance to traumas, causing their fragility and, consequently, a greater probability of the occurrence of fractures. In this way, BMD measurement will help in the diagnosis of osteopenia/osteoporosis and in the prevention of future bone fractures. In addition to bone densitometry, there are other methods, less invasive and less expensive, that effectively analyze BMD. CP is characterized as a permanent, though not invariable, disturbance of movement and posture due to a non-progressive defect or lesion of the brain early in life. (Rosa, A.C.A. & Matos, M.R. (2017)) Depending on the area of the nervous system affected, the patient with CP presents neuromuscular alterations. Each change will compromise differently and to different degrees, affecting the functional performance of these patients.